TY  - GEN 
AU  - Carrasco Campos, María Isabel
AU  - Pérez Ramírez, Cristina
AU  - Macías‑Cortés, Elena
AU  - Puerta García, Elena
AU  - Sánchez Pozo, Antonio
AU  - Arnal‑García, Carmen
AU  - Barrero Hernández, Francisco Javier
AU  - Calleja Hernández, Miguel Ángel
AU  - Jiménez Morales, Alberto
AU  - Cañadas Garre, Marisa
PY  - 2021
UR  - https://hdl.handle.net/10481/92911
AB  - First-line therapy with interferon beta (IFN-β), involved in gene expression modulation in immune response, is widely used for multiple sclerosis. However, 30–50% of patients do not respond optimally. Variants in CBLB, CTSS, GRIA3, OAS1 and TNFRSF10A...
LA  - eng
PB  - Springer Nature
KW  - Multiple sclerosis
KW  - Interferon beta
KW  - Response
KW  - Polymorphisms
TI  - Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis
DO  - 10.1007/s12035-021-02454-2
ER  -